Home › Funds › Flagship Pioneering, LLC › GENB

Flagship Pioneering, LLC position in GENB

GENERATE BIOMEDICINES INC · Health Care

Flagship Pioneering, LLC reported holding 62,673,117 shares of GENB (GENERATE BIOMEDICINES INC) in its Q2 2026 13F filing — a position valued at US$1.06B, representing 68.66% of its reported portfolio and ranking #1 among its reported holdings. Flagship Pioneering, LLC has disclosed GENB holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)62.67M sh
Reported value held$1.06B
Portfolio Weight68.66%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Flagship Pioneering, LLC's GENB position evolved

Flagship Pioneering, LLC first disclosed a stake in GENB in Q1 2026 at 62,673,117 shares (US$783.4M). The position peaked in Q2 2026 at 62,673,117 shares, worth US$1.06B. Across 2 filings, Flagship Pioneering, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 62,673,117 shares valued at US$1.06B.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 62.67M $783.41M New
Q2 2026 62.67M $1.06B Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GENB and 13F data

GENB (GENERATE BIOMEDICINES INC) is a Health Care company. 96 other funds we track also report a position in GENB — the largest reported positions include BRAIDWELL LP (US$55.4M), ARCH Venture Management, LLC (US$32.8M), HARBOURVEST PARTNERS LLC (US$29.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GENB

All GENB fund holders →

FAQ

How long has Flagship Pioneering, LLC held GENB?

Flagship Pioneering, LLC has disclosed GENB holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Flagship Pioneering, LLC's current position in GENB?

As of Q2 2026, Flagship Pioneering, LLC holds 62.67M shares of GENB (GENERATE BIOMEDICINES INC), valued at $1.06B, representing 68.66% of its reported portfolio and ranking #1.

Has Flagship Pioneering, LLC been buying or selling GENB?

In the latest 13F filing (Q2 2026), Flagship Pioneering, LLC held unchanged its position in GENB. The position peaked in Q2 2026 at 62.67M shares.

Which other funds hold GENB?

Other major institutional holders of GENB include BRAIDWELL LP, ARCH Venture Management, LLC, HARBOURVEST PARTNERS LLC, among 96 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.